-
-
-
-
-
-
-
Leerink Partners on Ultragenyx Pharma (RARE): FDA BLA acceptance positions co for two approvals, $150M oppty
-
-
-
-
-
-
-
Ultragenyx Pharma (RARE) PT Lowered to $79 at Canaccord Genuity
-
-
-
-
-
-
-
Ultragenyx Pharma (RARE) PT Lowered to $58 at BofA Securities
-
-
-
-
-
-
-
Ultragenyx Pharma (RARE) PT Lowered to $70 at Leerink Partners
-
-
-
-
-
-
-
Leerink Partners Reiterates Outperform Rating on Ultragenyx Pharma (RARE)
-
-
-
-
-
-
-
Ultragenyx Pharma (RARE) Misses Q3 EPS by 58c, provides guidance
-
-
-
-
-
-
-
Ultragenyx Pharma (RARE) December options active
-
446,889 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

